Severe COPD turned every breath into work. Your doctor added Daliresp to your treatment plan, explaining it would reduce how often you experience flare-ups that send you to the emergency room or require antibiotics and steroids. Fewer exacerbations meant better lung function and fewer hospitalizations. You agreed immediately because the cycle of COPD crises was exhausting and frightening. Then you picked up the first prescription and saw what this prevention would cost you every single month.
The Rx Advocates enrolls COPD patients in Patient Assistance Programs (PAPs) that adjust medication costs according to household income instead of pharmacy retail pricing.
What is the Daliresp Patient Assistance Program?
Drug companies maintain specialized programs for patients battling severe COPD who lack the financial resources to pay retail drug prices. Applicants meeting income requirements receive Daliresp at substantially discounted rates, preventing cost barriers from forcing them to skip doses or abandon treatment that keeps them out of the hospital.
You’ll submit your prescription alongside documentation of what your household earns. Our staff handles everything else: compiling your application materials, working with your pulmonologist’s office on necessary paperwork, filing with the manufacturer, and monitoring your application until approval comes through. Once you’re in the program, Daliresp ships to your home each month.
We operate as a patient advocacy organization. Our relationships with pharmaceutical manufacturers let us connect COPD patients across the country to programs that price medications based on financial need rather than market rates.
How to Qualify
Program eligibility centers primarily on annual household earnings:
- Single individuals making under $40,000 yearly
- Couples with combined income below $60,000 per year
- Families of three or more earning less than $100,000 annually
- Current valid prescription from your treating physician
Meeting these income thresholds doesn’t automatically mean acceptance. Different manufacturers use different specific criteria when evaluating applications. Reach out to us for an assessment of your individual situation and to determine whether or not you qualify.
Cost of Daliresp
with The Rx Advocates
The monthly service fee depends on the number of medications you take. For example:
$80 / Month
$90 / Month
$100 / Month
$110 / Month
NOTE: In addition to our monthly service fee, we charge a one-time enrollment fee of $35.
Our service is month-to-month, so if you’re not happy with it, you may cancel at any time.
The Rx Advocates Can Help Reduce Daliresp Costs
You’ll pay us one fixed monthly amount determined entirely by how many different medications you need help accessing. That amount never increases regardless of whether Daliresp retail prices go up or down.
COPD requires lifelong management, not temporary fixes. Our service addresses various insurance challenges: policies that provide inadequate prescription coverage, deductibles set so high they’re meaningless, or employment situations where health insurance simply isn’t offered.
We don’t deal in coupons or discount cards. Our work involves managing enrollment in pharmaceutical company programs that deliver reliable medication access at prices dramatically lower than what pharmacies charge.
Cost of Daliresp vs Other Options
$80.00/month
$564.57
* Source: GoodRx.com
Last Updated: September 29, 2025. Actual retail prices may vary by pharmacy and location.
Why Patient Assistance Programs Beat Coupons
Coupons might help with one refill. Assistance programs address the long-term affordability problem.
Coupon limitations
- Pharmacy restrictions: Valid only at participating stores
- Copay accumulators: Won’t count toward your annual deductible
- Expiration dates: Useless after short time periods
- Coverage gaps: Minimal help when dealing with expensive drugs
- Redemption requirements: Must bring physical coupon to counter
PAP advantages
- Substantial savings: Reductions that dwarf typical coupon discounts
- Reliable access: Consistent supply without hunting for deals
- Predictable costs: Stable fees regardless of price changes
- Convenient delivery: Medication mailed directly to you
Frequently Asked Questions (FAQ)
We’ve compiled answers to some of the most common questions about Daliresp and patient assistance programs.
With The Rx Advocates, patients pay a fixed monthly service fee, which depends on the number of medications covered.
- 1 Medication (Daliresp only) – $80 per month
- 2 Medications (Daliresp + 1 other) – $90 per month
- 3 Medications (Daliresp + 2 others) – $100 per month
- 4+ Medications – $110 per month
Importantly, there are no hidden fees, and prices remain consistent even if retail costs fluctuate.
Without enrollment in a patient assistance program, Daliresp costs more than many COPD patients can reasonably afford. What the pharmacy charges you depends on factors you can’t influence.
Multiple variables shape your final out-of-pocket expense:
- Dosage: The strength and quantity your doctor prescribes
- Location: Regional differences in drug pricing across the country
- Pharmacy: Independent pharmacies and chains set their own prices
- Insurance Coverage: Your plan determines what percentage you pay
Two COPD patients taking identical prescriptions can face vastly different costs based solely on which pharmacy they use, where they live, and what insurance coverage they have.
General income cutoffs hover around $40k for individuals, $60k for two-person households, and $100k for larger families. These serve as basic guidelines, though. Each manufacturer establishes its own detailed qualification standards, which is why we evaluate every application on its own merits.
We manage your entire enrollment and handle all ongoing refills. This includes collecting necessary documentation from your pulmonologist, completing manufacturer application forms correctly, submitting complete packages on schedule, and arranging automatic monthly shipments so you never run short.
About Daliresp
Daliresp is an oral medication containing roflumilast used to reduce COPD exacerbations in patients with severe disease and chronic bronchitis.
How it works: Roflumilast is a phosphodiesterase-4 (PDE-4) inhibitor that reduces inflammation in the lungs. By decreasing inflammation, it helps lower the frequency of COPD flare-ups that cause severe symptoms and often require emergency treatment or hospitalization.
Administration: Taken as a tablet once daily, with or without food. Your doctor typically starts you on a lower dose for the first month, then increases to the maintenance dose. Consistent daily use is essential since this medication prevents exacerbations rather than treating acute symptoms.
Side effects:
- Common: Diarrhea, weight loss, nausea, headache, back pain
- Serious: Severe mood changes, suicidal thoughts, psychiatric symptoms, significant weight loss, liver problems
Important warnings: Daliresp can cause psychiatric side effects including depression, anxiety, and suicidal thoughts. Tell your doctor immediately if you experience mood changes, unusual behavior, or thoughts of self-harm. This medication may cause significant weight loss. Your doctor should monitor your weight regularly during treatment. Inform your doctor about all medications you’re taking as Daliresp interacts with several common drugs.
Get Started Today
COPD exacerbations accelerate lung function decline and increase mortality risk. Each severe flare-up damages your lungs further and makes the next one more likely. Skipping Daliresp to save money might seem reasonable short-term, but it increases your chances of hospitalization that costs thousands of dollars and harms your health permanently.
Manufacturers fund these assistance programs specifically because they understand their pricing creates genuine access problems for patients who need these medications to stay alive and out of hospitals.
Contact us today to find out whether you qualify for programs that make Daliresp affordable on your budget.
